Merck’s COVID pill shows lower efficacy in updated study

by
from Al Jazeera – Breaking News, World News and Video from Al Jazeera on (#5SCSD)
Story ImageDrugmaker says final analysis of trial results showed molnupiravir showed 30 percent risk reduction.
External Content
Source RSS or Atom Feed
Feed Location https://www.aljazeera.com/xml/rss/all.xml
Feed Title Al Jazeera – Breaking News, World News and Video from Al Jazeera
Feed Link https://www.aljazeera.com/
Feed Copyright © 2026 Al Jazeera Media Network
Reply 0 comments